Skip to main content

Aptinyx Inc.

APTXDelisted Jul 10, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001674365

Aptinyx Inc. was delisted on Jul 10, 2023; its insiders filed their last Form 4 on Jan 5, 2023; 32 institutions reported holding it in 13F filings for Q1 2023, worth $2.44M in total; no superinvestor held it.

Q1 2023 vs. Q4 2022

How the institutions holding Aptinyx Inc. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of APTX: Q4 2022 compared with Q1 2023
MeasureQ4 2022Q1 2023Change
Holders3532−3
Shares29.1M19.8M−9.35M (−32.1%)
Value$8.33M$2.44M−$5.89M (−70.7%)

New holders (4)

Institutions that held Aptinyx Inc. at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to APTX in Q1 2023
InstitutionSharesValue% of portfolio
Virtu Financial LLC280,430$35.0K0.00%
Two Sigma Securities, LLC52,949$6.61K0.00%
LPL Financial LLC40,000$4.99K0.00%
Simplex Trading, LLC100$00.00%

Sold out (7)

Institutions that held Aptinyx Inc. at the end of Q4 2022 and filed for Q1 2023 without it.

Institutions that sold out of APTX in Q1 2023
InstitutionShares, Q4 2022Value, Q4 2022
Artal Group S.A.6,116,493$1.75M
Frazier Life Sciences Management, L.P.1,883,244$537.3K
Point72 Asset Management, L.P.410,416$117.1K
Jane Street Group, LLC103,039$29.4K
Citadel Advisors LLC25,973$7.61K
UBS Group AG462$134
HBK Sorce Advisory LLC52,000–